Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by capebretongirlon Feb 25, 2021 3:33pm
225 Views
Post# 32660597

RE:B E A R I S H ! ! !

RE:B E A R I S H ! ! !
TrippingAgain2 wrote: This may be a blood bath by the end of Q1. I pray for all the holders. I was considering swinging this in late march, but honestly I just cant believe this will turn out well. Risk is too high even for me that NR does more harm than good.

Although Tripp tried not to make false statements or projections which is a step forward, he has locked himself into crazy high expectations for Aristotle now. (Due to no transparacy due to their management team being very low grade) I cant tell all you fresh newbies how many times Tripp statement have been misread by investors in the past. To many to count. The main reason is beause they are non-transparent and secretive which cause confusion and guessing from investors. (remeber the tables being made for the millions and millions some investors thought might happen last Q becuase TRipps statements)

Many people think they will get a finsihed product ready to launch and make SZLS money, but as I was saying LONGGGGGG ago and if you read carefully... "Aristotle will begin to launch at end of Q1" is all that is stated. This can be interpreted in many ways we dont know yet. SZLS may still be very very far away from a totally finished product.

If you have followed this company for years, the olny time the SP runs up is EXCLUSIVELY on rumours or expectations. NEVER ANYTHING REAL or LEGIT. Then it gets dumped by insiders and retial is always left their holding bags.

** I have been down of this company for some time and do bash them because I think they are fraudulent or at least a very weak company so you all know. Maybe this is a turning point for company after years or research. BUT THEY GIVE NOTHING FOR ME TO BELIEVE SO.

Where are the partnerships if Aristotle is about to launch ASAP? Wasnt everyone pumped when ColonSentry waas launched? When Oncore 40 million USD deal was signed? How did that end up? 




You are defeating your own logic with your quote:if you have followed this company for years, the olny time the SP runs up is EXCLUSIVELY on rumours or expectations. NEVER ANYTHING REAL or LEGIT. Unquote

So I guess you are saying that the Q3 revenue was a lie and that Q4, Q1, Q2 revenue from Covid will be non existent - as you said - NEVER ANYTHING REAL OR LEGIT. 
<< Previous
Bullboard Posts
Next >>